Drug discovery is slow, expensive, and prone to failure because promising targets and responsive patient groups are difficult to identify early.
R&D Focus
Genomics and multi-omics for patient stratification and treatment selection
Innovative Solution
InnoMab uses big data and AI calculations to develop targeted drugs and precision medicine tools. They use proteomics technology and disease model libraries like PDX/PDO to create a unique platform for drug development.
Investment Funding
Last Funding Stage
Seed
Last Funding Date
23-07-2024
Startup Stage
Seed
Lead Investors
Dandelion Venture Capital
About
InnoMab uses big data and AI calculations to develop targeted drugs and precision medicine tools. They use proteomics technology and disease model libraries like PDX/PDO to create a unique platform for drug development. This technology supports key research links, including target discovery, drug mechanism, patient selection, and clinical decision-making.
Something missing or incorrect on this page? Help us enrich this information
